Provided by Tiger Trade Technology Pte. Ltd.

Ultragenyx Pharmaceutical

15.22
+0.47003.19%
Post-market: 15.05-0.1700-1.12%19:54 EDT
Volume:3.88M
Turnover:58.72M
Market Cap:1.50B
PE:-2.61
High:15.28
Open:14.90
Low:14.67
Close:14.75
52wk High:39.89
52wk Low:12.73
Shares:98.32M
Float Shares:80.72M
Volume Ratio:0.82
T/O Rate:4.81%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.8279
EPS(LYR):-5.8316
ROE:-608.47%
ROA:-24.22%
PB:-5.14
PE(LYR):-2.61

Loading ...

Ultragenyx Pharmaceutical - Fayuvi Expected to Ship to Qualified Treatment Centers Within 30-60 Days

THOMSON REUTERS
·
Sep 18

Ultragenyx Sets $3.95 Million Price for Rare Disease Gene Therapy

Reuters
·
Sep 18

US FDA Approves Ultragenyx's Gene Therapy for Rare Disorder

Reuters
·
Sep 18

FDA: Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A

THOMSON REUTERS
·
Sep 18

Ultragenyx call volume above normal and directionally bullish

TIPRANKS
·
Sep 17

Ultragenyx treatment of GNE myopathy granted orphan designation

TIPRANKS
·
Sep 15

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Intellia Therapeutics (NTLA) and Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 08

Ultragenyx price target lowered to $32 from $43 at Barclays

TIPRANKS
·
Sep 04

Sector Update: Healthcare Stocks Higher Thursday Afternoon

MT Newswires Live
·
Sep 04

Nvidia, Tesla, Robinhood, Snowflake, Ultragenyx, Ciena, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 04

Ultragenyx downgraded to Equal Weight from Overweight at Morgan Stanley

TIPRANKS
·
Sep 04

Ultragenyx falls -44.0%

TIPRANKS
·
Sep 04

Ultragenyx Pharmaceutical Down over 45%, on Pace for Record Low Close and Record Percent Decrease

Dow Jones
·
Sep 03

Ultragenyx Hits Record Low After Rare Disease Drug Trial Failure

Reuters
·
Sep 03

Why Is Ultragenyx Pharmaceutical Stock (RARE) Down Today?

TIPRANKS
·
Sep 03

U.S. Stocks on the MOVE-Gold Miners, Polestar Automotive, Nvidia

Reuters
·
Sep 03

Ultragenyx price target lowered to $28 from $77 at Jefferies

TIPRANKS
·
Sep 03

Wedbush Keeps Their Hold Rating on Ultragenyx Pharmaceutical (RARE)

TIPRANKS
·
Sep 03

Ultragenyx price target lowered to $33 from $103 at Cantor Fitzgerald

TIPRANKS
·
Sep 03

Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE) and Lifecore Biomedical (LFCR)

TIPRANKS
·
Sep 03